Help us create a future without liver disease.

Our platform technology allows human liver cells to be created in quantity and quality that has never been achievable before.

There’s a great and growing need for functional liver cells (hepatocytes).

A HEART-BREAKING HUMAN COST

100 million

Americans suffer from liver disease

51,462

U.S. adults died from liver disease in 2020*

*SOURCE: AMERICAN LIVER FOUNDATION

MASSIVE MARKET DEMAND

$35+
billion

U.S. Market revenue opportunity (Cell transplantation, liver assist device, research)

Liver Diseases
Rare Genetic Diseases
Blood Diseases
Cancers
Cirrhosis
Liver Failure
Alcoholic Hepatitis
Liver Diseases
Rare Genetic Diseases
Blood Diseases
Cancers
Cirrhosis
Liver Failure
Alcoholic Hepatitis
Liver Diseases
Rare Genetic Diseases
Blood Diseases
Cancers
Cirrhosis
Liver Failure
Alcoholic Hepatitis
Liver Diseases
Rare Genetic Diseases
Blood Diseases
Cancers
Cirrhosis
Liver Failure
Alcoholic Hepatitis
Liver Diseases
Rare Genetic Diseases
Blood Diseases
Cancers
Cirrhosis
Liver Failure
Alcoholic Hepatitis
Liver Diseases
Rare Genetic Diseases
Blood Diseases
Cancers
Cirrhosis
Liver Failure
Alcoholic Hepatitis
Liver Diseases
Rare Genetic Diseases
Blood Diseases
Cancers
Cirrhosis
Liver Failure
Alcoholic Hepatitis
Liver Diseases
Rare Genetic Diseases
Blood Diseases
Cancers
Cirrhosis
Liver Failure
Alcoholic Hepatitis
Liver Diseases
Rare Genetic Diseases
Blood Diseases
Cancers
Cirrhosis
Liver Failure
Alcoholic Hepatitis
Liver Diseases
Rare Genetic Diseases
Blood Diseases
Cancers
Cirrhosis
Liver Failure
Alcoholic Hepatitis
Liver Diseases
Rare Genetic Diseases
Blood Diseases
Cancers
Cirrhosis
Liver Failure
Alcoholic Hepatitis

Doctors and researchers are on the verge of breakthroughs, but are limited by a

lack of cells.

We’re ready to meet that need with the new gold standard.

Greater Quantity

Our bio-incubator expands cells up to 1000x

Higher Quantity

Pure primary hepatocytes, ready to use

Solid Reliability

Platform technology enables consistent product

Crucial Scalability

The only platform that can scale up to meet demand

The Result:

New treatments, cures and therapies available to more people.

We’re making it happen now.

Proven Patented Technologies

Bio-Incubator

Liver Assist Device

Allogeneic Hepatocytes (Patent-pending)

World-Class Affiliations

Help us create a future without liver disease.